Search

everythinglearnresearchcommunity

for

Search:↓

Local injections of nanosized rhEPO can speed up skin healing and improve quality after deep second-degree burns.

PRP may help treat hair loss, but results vary.

The effectiveness of platelet-rich plasma is unclear due to inconsistent preparation methods.

PRP shows promise for treating hair loss but needs standardized methods to confirm its effectiveness.

Platelet-rich plasma therapy is widely used in medicine for its effectiveness and safety, but more research is needed to fully understand its potential.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

Tirzepatide may improve hair loss by reducing insulin resistance.

Intravenous delivery of autologous activated platelet-rich plasma is safe.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

The FDA approved a new Pfizer drug for hair loss in teens.

AA-PRP injections significantly promote hair growth but need better study design for clear efficacy.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

The developed system could effectively treat hair loss and promote hair growth.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Newer GLP-1 drugs like semaglutide may cause hair loss.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.